(Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...

Hypertrophic scarring affects a large proportion of patients following burns, trauma, or surgery and arises from prolonged fibroblast hyperactivity and excessive extracellular matrix accumulation.

The global cell and gene therapy market is forecast to surge from $10.4 billion to more than $45 billion by 2035, with over 40 FDA-approved products and North America commandi ...

Immutep has completed the single ascending dose (SAD) portion of its IMP761 study IMP761 was well tolerated across all dose levels IMP761 data ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Christina Applegate is candidly revealing the horrific reality of living with multiple sclerosis in her new memoir. The Emmy-winning actress was diagnosed with the chronic autoimmune disease in June ...

Christina Applegate is detailing the “dangerous” and “scary” weight loss she’s experienced amid her battle with multiple sclerosis (MS) in her new memoir. “Sometimes the weight bothered me more than ...

A second phase 3 study of Roche’s fenebrutinib in relapsing multiple sclerosis (RMS) has hit its primary endpoint, positioning the company to submit the BTK inhibitor for approval. But the discovery ...